Detalhe da pesquisa
1.
Survival of cancer patients in Fujian, Southeast China: a population-based cancer registry study.
Neoplasma
; 68(4): 892-898, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34034497
2.
A senescence-related lncRNA signature predicts prognosis and reflects immune landscape in HNSCC.
Oral Oncol
; 149: 106659, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134702
3.
An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status.
Biomed Res Int
; 2023: 1189022, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36704723
4.
Development and validation of a model based on immunogenic cell death related genes to predict the prognosis and immune response to bladder urothelial carcinoma.
Front Oncol
; 13: 1291720, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023241
5.
PYHIN1 correlates with CD8+ T cells infiltration and confers good patient survival in oral cancer.
J Dent Sci
; 17(1): 551-559, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028083
6.
FAM3D as a Prognostic Indicator of Head and Neck Squamous Cell Carcinoma Is Associated with Immune Infiltration.
Comput Math Methods Med
; 2022: 5851755, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36510584
7.
Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study.
Ann Transl Med
; 10(24): 1316, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36660709
8.
N6-methyladenosine modification of CENPK mRNA by ZC3H13 promotes cervical cancer stemness and chemoresistance.
Mil Med Res
; 9(1): 19, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35418160
9.
An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.
Front Immunol
; 13: 1022598, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36505399
10.
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.
Cancer Commun (Lond)
; 41(11): 1195-1227, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34699681
11.
Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Chin J Cancer
; 29(2): 145-50, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20109341
12.
Association of Tumor Protein p53 and Ataxia-Telangiectasia Mutated Comutation With Response to Immune Checkpoint Inhibitors and Mortality in Patients With Non-Small Cell Lung Cancer.
JAMA Netw Open
; 2(9): e1911895, 2019 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31539077
13.
[Multi-center phase II clinical trial of humanized anti-epidermal factor receptor monoclonal antibody h-R3 combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma].
Zhonghua Zhong Liu Za Zhi
; 29(3): 197-201, 2007 Mar.
Artigo
em Zh
| MEDLINE | ID: mdl-17649636
14.
[Recombinant adenovirus p53 agent injection combined with radiotherapy in treatment of nasopharyngeal carcinoma: a phase II clinical trial].
Zhonghua Yi Xue Za Zhi
; 83(23): 2033-5, 2003 Dec 10.
Artigo
em Zh
| MEDLINE | ID: mdl-14703410
15.
[Measurement of setup error in conformal radiotherapy for nasopharyngeal carcinoma].
Ai Zheng
; 25(1): 115-8, 2006 Jan.
Artigo
em Zh
| MEDLINE | ID: mdl-16405764